<?xml version="1.0"?>

<document>
	<title>Pathogenesis of cystic fibrosis: possible importance of alteration
   in epithelial surface topography.</title>

	<author>Danes-B-S.</author>
	<author>Sutanto-E.</author>

	<source>Med-Hypotheses. 1979 Feb. 5(2). P 289-95.</source>

	<abstract>As the pathogenesis in cystic fibrosis (CF) has been considered to
   lie in a disturbance in the behavior of secretions, particularly
   mucins, from exocrine glands, it has been proposed that an alteration
   in surface topography (form, number or distribution of microvilli or
   blebs) of epithelial cells lining ducts could impair distribution
   leading to retention of mucus leading to the clinical phenotype.
   Scanning electronmicroscopy of human epithelial suspension cultures
   now offers an opportunity to evaluate the role of plasmalemma
   topography in CF.</abstract>

	<majorsubject>CYSTIC-FIBROSIS: et</majorsubject>
	<majorsubject>LUNG: ul</majorsubject>

	<minorsubject>CELL-MEMBRANE: ul</minorsubject>
	<minorsubject>EPITHELIUM: ul</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>MICROSCOPY-ELECTRON-SCANNING</minorsubject>
	<minorsubject>MUCOUS-MEMBRANE: ph</minorsubject>
	<minorsubject>MUCUS: ph</minorsubject>

	<reference>001   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967</reference>
	<reference>002   ANDERSEN DH           ANN NY ACAD SCI                 93   500 962</reference>
	<reference>003   DI SANTAGNESE PA      ANN NY ACAD SCI                 93   555 962</reference>
	<reference>004   DANES BS              BIRTH DEF ORIG ART SER           8   114 972</reference>
	<reference>006   FELIX JS              AM J HUM GENET                  29   41A 977</reference>
	<reference>007   ANDREWS PM            AM J ANAT                      139   399 974</reference>
	<reference>008   ANDREWS PM            J CELL BIOL                     67   11A 975</reference>
	<reference>009   MISHIMA Y             ACTA DERM VENEREOL SUPPL 73     53    83 973</reference>
	<reference>010   DAWBER RPR            BR J DERMATOL                   86   272 972</reference>
	<reference>011   ORFANOS CE            ARCH DERMATOL                  107    38 973</reference>
	<reference>012   STEINRUD J            DAN MED BULL                    21   251 974</reference>
	<reference>013   DANKS DM              ANN HUM GENET                   28   323 965</reference>
	<reference>014   FARBER S              J MICH MED SOC                  44   587 945</reference>
	<reference>015   JOHANSEN PG           LANCET                           1   455 968</reference>
	<reference>016   GIBSON LE             LANCET                           2   189 970</reference>
	<reference>017   TILLMAN B             CELL TISSUE RES                185   279 977</reference>
	<reference>018   BAUR PS               TEX REP BIOL MED                34   113 976</reference>
	<reference>019   PORTER KR             J CELL BIOL                     57   815 973</reference>
	<reference>020   ANDREWS PM            AM J ANAT                      140    81 974</reference>
	<reference>021   SYLVEN B              ACTA HISTOCHEM SUPPL             1    79 958</reference>
	<reference>022   DANES BS              J EXP MED                      123     1 966</reference>
	<reference>023   DANES BS              BIOCHEM BIOPHYS RES COMMUN      36   919 969</reference>
	<reference>024   SPOCK A               PEDIATR RES                      1   173 967</reference>
	<reference>025   DANES BS              J EXP MED                      136  1313 972</reference>

	<citation>1   THEOHARIDES TC        LIFE SCI                        27   703 980</citation>
	<citation>2   MICHALSEN H           PATHOL RES PRACT               178   261 984</citation>

</document>
